Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Market Rotation
View:
Post by inventors on Jul 21, 2022 1:05pm

Market Rotation

Invested in LABU..$4/5/6...LMNL carrying forward loss, but double back in.

LMNL could retrace...0.47...double bottom 0.35, but one may not get the chance..?

LABU $9...LMNL 0.53 - -.56...?

Some chart patterns showing falling wedge, or a xmas tree wedge in making, or sideways rectangular pattern...waiting for end of month...int rates...market readiness...?

LMNL should have some interesting milestones, and a better balance sheet than before.
Comment by balain on Jul 21, 2022 4:14pm
Once again inventors, why are you drooling at the prospects of phase 1 results when it took the company 24 years to get multiple products approved, completed phase 3, completed phase 2 and so forth, just to get rid of them for peanuts and start fresh with pre-clinical products? Even Pritchard and Sartore must be wondering what flavour and how much of it you're smoking, but I'm sure they ...more  
Comment by balain on Jul 21, 2022 4:26pm
I can't even begin to comprehend how you can still trust management after the way they handled the company at the end of 2018 / beginning of 2019. Not only they did manage to fail bringing unfailable products to market but they achieve complete destruction of Prometic, while getting promoted to top jobs within Liminal. How do you explain that and why wouldn't they do it again? Those guys ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities